Literature DB >> 11915947

Recent advances in the genetics of schizophrenia.

D M Waterwort1, A S Bassett, L M Brzustowicz.   

Abstract

The genetic etiology of schizophrenia, a common and debilitating psychiatric disorder, is supported by a wealth of data. Review of the current findings suggests that considerable progress has been made in recent years, with a number of chromosomal regions consistently implicated by linkage analysis. Three groups have shown linkage to 1q21-22 using similar models, with HLOD scores of 6.5, 3.2, and 2.4. Other replicated loci include 13q32 that has been implicated by two independent groups with significant HLOD scores (4.42) or NPL values (4.18), and 5pl4.1-13.1, 5q21-33, 8p2l-22, and 10p11-15, each of which have been reported as suggestive by at least three separate groups. Different studies have also replicated evidence for a modest number of candidate genes that were not ascertained through linkage. Of these, the greatest support exists for the DRD3 (3q13.3), HTR2A (13q14.2), and CHRNA7 (15q13-q14) genes. The refinement of phenotypes, the use of endophenotypes, reduction of heterogeneity, and extensive genetic mapping have all contributed to this progress. The rapid expansion of information from the human genome project will likely further accelerate this progress and assist in the discovery of susceptibility genes for schizophrenia. A greater understanding of disease mechanisms and the application of pharmacogenetics should also lead to improvements in therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11915947      PMCID: PMC3169644          DOI: 10.1007/s00018-002-8426-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  144 in total

1.  The NOTCH4 locus is associated with susceptibility to schizophrenia.

Authors:  J Wei; G P Hemmings
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

2.  Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia.

Authors:  P Eichhammer; M Albus; M Borrmann-Hassenbach; A Schoeler; A Putzhammer; U Frick; H E Klein; T Rohrmeier
Journal:  Am J Med Genet       Date:  2000-04-03

3.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

Authors:  D Altshuler; J N Hirschhorn; M Klannemark; C M Lindgren; M C Vohl; J Nemesh; C R Lane; S F Schaffner; S Bolk; C Brewer; T Tuomi; D Gaudet; T J Hudson; M Daly; L Groop; E S Lander
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

4.  Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families.

Authors:  B P Riley; A Makoff; M Mogudi-Carter; T Jenkins; R Williamson; D Collier; R Murray
Journal:  Am J Med Genet       Date:  2000-04-03

5.  Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia.

Authors:  H Tachikawa; S Harada; Y Kawanishi; T Okubo; H Shiraishi
Journal:  Am J Med Genet       Date:  2000-04-03

6.  Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III.

Authors:  D F Levinson; P Holmans; R E Straub; M J Owen; D B Wildenauer; P V Gejman; A E Pulver; C Laurent; K S Kendler; D Walsh; N Norton; N M Williams; S G Schwab; B Lerer; B J Mowry; A R Sanders; S E Antonarakis; J L Blouin; J F DeLeuze; J Mallet
Journal:  Am J Hum Genet       Date:  2000-08-02       Impact factor: 11.025

7.  Relative risk of attention deficits in siblings of patients with schizophrenia.

Authors:  M F Egan; T E Goldberg; T Gscheidle; M Weirich; L B Bigelow; D R Weinberger
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

8.  Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia.

Authors:  R Kaiser; M Könneker; M Henneken; M Dettling; B Müller-Oerlinghausen; I Roots; J Brockmöller
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

9.  A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.

Authors:  V S Basile; V Ozdemir; M Masellis; M L Walker; H Y Meltzer; J A Lieberman; S G Potkin; G Alva; W Kalow; F M Macciardi; J L Kennedy
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

10.  Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia.

Authors:  H Ishiguro; Y Okuyama; M Toru; T Arinami
Journal:  Mol Psychiatry       Date:  2000-07       Impact factor: 15.992

View more
  8 in total

1.  Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study.

Authors:  Shelly L Babin; Ashley J Hood; Adel A Wassef; Nina G Williams; Saumil S Patel; Anne B Sereno
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-06-13       Impact factor: 5.067

2.  RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility.

Authors:  Christina G S Palmer; Joni A Turunen; Janet S Sinsheimer; Sonia Minassian; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; J Arthur Woodward
Journal:  Am J Hum Genet       Date:  2002-11-18       Impact factor: 11.025

3.  Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands.

Authors:  Bruce I Turetsky; Tiffany A Greenwood; Ann Olincy; Allen D Radant; David L Braff; Kristin S Cadenhead; Dorcas J Dobie; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Gregory A Light; James Mintz; Keith H Nuechterlein; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Monica E Calkins
Journal:  Biol Psychiatry       Date:  2008-08-13       Impact factor: 13.382

Review 4.  Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorder.

Authors:  Ping-I Lin; Braxton D Mitchell
Journal:  Schizophr Bull       Date:  2008-05-22       Impact factor: 9.306

5.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

6.  Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Appl Clin Genet       Date:  2012-02-20

7.  Neural network analysis in pharmacogenetics of mood disorders.

Authors:  Alessandro Serretti; Enrico Smeraldi
Journal:  BMC Med Genet       Date:  2004-12-09       Impact factor: 2.103

8.  Mutation screening of two candidate genes from 13q32 in families affected with Bipolar disorder: human peptide transporter (SLC15A1) and human glypican5 (GPC5).

Authors:  Manjula Maheshwari; S L Christian; C Liu; J A Badner; S Detera-Wadleigh; E S Gershon; Richard A Gibbs
Journal:  BMC Genomics       Date:  2002-10-22       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.